Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

2.

[Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].

Azorin JM, Llorca PM, Despiegel N, Verpillat P.

Encephale. 2004 Mar-Apr;30(2):158-66. French.

PMID:
15107719
3.
4.

Efficacy of escitalopram compared to citalopram: a meta-analysis.

Montgomery S, Hansen T, Kasper S.

Int J Neuropsychopharmacol. 2011 Mar;14(2):261-8. doi: 10.1017/S146114571000115X. Epub 2010 Sep 29. Review.

PMID:
20875220
5.

Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.

Kennedy SH, Andersen HF, Lam RW.

J Psychiatry Neurosci. 2006 Mar;31(2):122-31. Erratum in: J Psychiatry Neurosci. 2006 Jul;31(4):228.

6.
7.

Escitalopram in the treatment of major depressive disorder: a meta-analysis.

Kennedy SH, Andersen HF, Thase ME.

Curr Med Res Opin. 2009 Jan;25(1):161-75. doi: 10.1185/03007990802622726 .

PMID:
19210149
8.
9.

[Escitalopram for treatment of major depressive disorder in adults].

Llorca PM, Brousse G, Schwan R.

Encephale. 2005 Jul-Aug;31(4 Pt 1):490-501. Review. French.

PMID:
16389716
10.

A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients.

Boulenger JP, Huusom AK, Florea I, Baekdal T, Sarchiapone M.

Curr Med Res Opin. 2006 Jul;22(7):1331-41.

PMID:
16834832
13.

Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder.

Lepola U, Wade A, Andersen HF.

Int Clin Psychopharmacol. 2004 May;19(3):149-55. Erratum in: Int Clin Psychopharmacol. 2004 Jul;19(4):255.

PMID:
15107657
14.

Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data.

Wade AG, Fernández JL, François C, Hansen K, Danchenko N, Despiegel N.

Pharmacoeconomics. 2008;26(11):969-81.

PMID:
18850765
15.

Combining escitalopram with gaboxadol provides no additional benefit in the treatment of patients with severe major depressive disorder.

Kasper S, Ebert B, Larsen K, Tonnoir B.

Int J Neuropsychopharmacol. 2012 Jul;15(6):715-25. doi: 10.1017/S146114571100112X. Epub 2011 Oct 19.

PMID:
22008735
16.

[Efficacy of escitalopram and severity of depression: new data].

Spadone C.

Encephale. 2009 Dec;35(6):577-85. doi: 10.1016/j.encep.2009.10.004. Review. French.

PMID:
20004289
17.

Early non-response in patients with severe depression: escitalopram up-titration versus switch to duloxetine.

Bose A, Tsai J, Li D.

Clin Drug Investig. 2012 Jun 1;32(6):373-85. doi: 10.2165/11631890-000000000-00000.

PMID:
22559255
18.

An open-label multicentric study of the tolerability and response to escitalopram treatment in Indian patients with major depressive disorder.

Pinto C, Trivedi JK, Vankar GK, Sharma PS, Narasimha V.

J Indian Med Assoc. 2007 Jul;105(7):364, 366, 368 passim.

PMID:
18178988
19.

[Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].

Favré P.

Encephale. 2012 Feb;38(1):86-96. doi: 10.1016/j.encep.2011.11.003. Epub 2011 Dec 10. Review. French.

PMID:
22381728
20.

Supplemental Content

Support Center